Senators call for probe after hydroxychloroquine was administered to patients in nursing homes
In a letter, US Senators Bob Casey (D-PA), Elizabeth Warren (D-MA) and Ron Wyden (D-OR) called for a federal investigation into hydroxychloroquine use at two nursing homes, (Source: the Mail online | Health)
Source: the Mail online | Health - August 28, 2020 Category: Consumer Health News Source Type: news
Trump-backed hydroxychloroquine doesn't treat Covid-19 and raises the risk of death
A review of 29 studies showed the controversial hydroxychloroquine does not save lives when given to Covid-19 patients. The drug has been touted by President Donald Trump as a 'game changer'. (Source: the Mail online | Health)
Source: the Mail online | Health - August 27, 2020 Category: Consumer Health News Source Type: news
Oleandrin: Trump allies pitch extract from poisonous plant to fight Covid
Experts raise concern over compound that has not been proven safe but could reach public as dietary supplementAllies of Donald Trump have promoted a plant extract called oleandrin to people seeking to ward off Covid-19. The plant the extract is derived from, oleander, is poisonous and there is no proof the compound is either safe or effective to treat or prevent Covid-19, experts say.But unlike other unproven and potentially dangerous Covid-19 “cures” pitched by Trump and his supporters, including the prescription antimalarial hydroxychloroquine, experts fear this compound could easily reach the public as a dietary sup...
Source: Guardian Unlimited Science - August 25, 2020 Category: Science Authors: Jessica Glenza Tags: US healthcare Coronavirus outbreak Donald Trump US politics Trump administration Science US news Pharmaceuticals industry Source Type: news
Hydroxychloroquine plus azithromycin increases heart risk, finds global study
(Columbia University Irving Medical Center) In the largest observational study of hydroxychloroquine and azithromycin, the drug combination has been linked to significant cardiovascular risks, including death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2020 Category: International Medicine & Public Health Source Type: news
Hydroxychloroquine reduces in-hospital COVID-19 mortality
(Istituto Neurologico Mediterraneo Neuromed I.R.C.C.S.) An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic. The research, conducted on 3,451 patients treated in 33 hospitals throughout the Italian territory, shows that the use of this drug reduces by 30% the risk of death in hospitalized patients affected by Covid-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2020 Category: International Medicine & Public Health Source Type: news
FDA Authorizes Use of Plasma From Recovered Patients to Treat COVID-19
(WASHINGTON) — President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called “a breakthrough,” one of his top health officials called “promising” and other health experts said needs more study before it’s celebrated.
The announcement came after White House officials complained there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances.
On the eve of the Republican National Convention, T...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Jonathan Lemire an Mike Stobbe / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
Trump Suggests ‘Deep State’ At FDA Is Delaying Covid-19 Coronavirus Vaccine Testing
Trump also tweeted about the FDA's hydroxychloroquine decision. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 22, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Editors' Pick editors-pick pharma Source Type: news
Anti-malaria drug hydroxychloroquine does NOT prevent people from contracting coronavirus
A new study found about 34.6% of patients with lupus and/or rheumatoid arthritis taking the drug contracted coronavirus, just about as many as those with the conditions who didn't fall ill. (Source: the Mail online | Health)
Source: the Mail online | Health - August 19, 2020 Category: Consumer Health News Source Type: news
Coronavirus Doctors Battle Another Scourge: Misinformation
Physicians say they regularly treat people more inclined to believe what they read on Facebook than what a medical professional tells them. (Source: NYT Health)
Source: NYT Health - August 17, 2020 Category: Consumer Health News Authors: Adam Satariano Tags: Coronavirus (2019-nCoV) Rumors and Misinformation Doctors Social Media Hydroxychloroquine (Drug) Emergency Medical Treatment Twitter American Journal of Tropical Medicine and Hygiene Source Type: news
After Hydroxychloroquine, Trump Is Now Seeking To Get Another Unproven Drug Approved By The FDA: Report
A senior Trump administration official said attempts to push the product, reportedly endorsed by Ben Carson and CEO of MyPillow, should give American “no comfort at night” in the midst of the pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 17, 2020 Category: Pharmaceuticals Authors: Isabel Togoh, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Leadership /leadership Editors' Pick editors-pick Breaking breaking-news Coronavirus Source Type: news
New study: Hydroxychloroquine ineffective as a preventive antiviral against COVID-19
(Case Western Reserve University) Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population. Their findings were recently published in the Annals of the Rheumatic Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 17, 2020 Category: Infectious Diseases Source Type: news
More than 100 Americans have died after taking hydroxychloroquine for COVID-19
In the first six months of 293 people died after taking hydroxychloroquine, according to the Milwaukee Journal Sentinel's review of FDA data. More than half took it to treat coronavirus. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2020 Category: Consumer Health News Source Type: news
' Doubling Down' on Hydroxychloroquine QT Prolongation in COVID-19'Doubling Down' on Hydroxychloroquine QT Prolongation in COVID-19
Patients had progressively longer QT intervals with hydroxychloroquine plus azithromycin but also frequently received other drugs that had QT-prolonging effects in a new study.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 7, 2020 Category: Neurology Tags: Cardiology News Source Type: news
Hydroxychloroquine could save tens of thousands of lives from Covid-19 but it's been politicised
British researchers behind the only large global trial of hydroxychloroquine as a prophylaxis say their work is in jeopardy because the drug has become politicised thanks to Donald Trump. (Source: the Mail online | Health)
Source: the Mail online | Health - August 6, 2020 Category: Consumer Health News Source Type: news
Hydroxychloroquine being 'discarded prematurely', say scientists
Clinicians from global study say controversy around the drug is stopping them completing their study. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 6, 2020 Category: Consumer Health News Source Type: news
